Abstract
The transforming growth factor-ß (TGFß) family consists of structurally related polypeptides that mediate important physiological processes. Significant advances have been made recently in understanding the functions of these molecules in vivo by the targeted ablation of various members of the super gene family. The family members include the TGF(is, activins, inhibins, bone morphogenetic proteins, Müllerian-inhibiting substance, nodal, dorsalin,and the products of the Drosophila decapentaplegic, and Xenopus Vg-1 genes (for review see refs. 1–4). Recently, the growth differentiation factor (GDF) family of proteins, a new member of the TGFβ family, has been described (5–7). TGFβl was first isolated from human platelets (8) and the cDNA sequence was later determined (9). TGFß 1 is a disulfide-linked homo-dimer of two 112 amino acid chains. Each chain is synthesized as the C-terminal domain of a 390 amino acid precursor. It has the characteristics of a secretory polypeptide, contains a hydrophobic signal sequence for translocation across the endoplasmic reticulum, and is glycosylated. The precursor cleavage site is a sequence of four basic amino acids immediately preceding the bioactive domain (9).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Massague, J. (1990) The transforming growth factor-beta family. Ann. Rev. Cell Biol. 6, 597 - 641.
Kingsley, D. M. (1994) The TGF-beta superfamily. new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133 - 146.
Roberts, A. B. and Sporn, M. B. (1988) Transforming growth factor beta. Adv. Cancer Res. 51, 107 - 145.
Barnard, J. A., Lyons, R. M., and Moses, H. L. (1990) The cell biology of transforming growth factor beta. Biochim. Biophys. Acta 1032, 79 - 87.
Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A., Kingsley, D. M., and Lee, S. J. (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368, 639 - 643.
McPherron, A. C. and Lee, S. J. (1993) GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines. J. Biol. Chem. 268, 3444 - 3449.
Lee, S. J. (1991) Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proc. Nat. Acad. Sci. USA 88, 4250 - 4254.
Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., and Sporn, M. B. (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258, 7155 - 7160.
Derynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R., Assoian, R. K., Roberts, A. B., Sporn, M. B., and Goeddel, D. V. (1985) Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316, 701 - 705.
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994) Mechanism of activation of the TGF-beta receptor. Nature 370, 341 - 347.
Lopez-Casillas, F., Payne, H. M., Andres, J. L., and Massague, J. (1994) Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124, 557 - 568.
Lopez-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., and Massague, J. (1991) Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 67, 785 - 795.
Shull, M. M. and Doetschman, T. (1994) Transforming growth factor-beta 1 in reproduction and development. Mol. Reprod. Dey. 39, 239 - 246.
Wall, N. A. and Hogan, B. L. (1994) TGF-beta related genes in development. Curr. Opinion Genetics Dev. 4, 517 - 522.
Hoffmann, F. M. (1991) Transforming growth factor-beta-related genes in Drosophila and vertebrate development. Curr. Opinion Cell Biol. 3, 947 - 952.
Wahl, S. M. (1992) Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. J. Clin. Immunol. 12, 61 - 74.
Ruscetti, F. W. and Palladino, M. A. (1991;) Transforming growth factor-beta and the immune system. Prog. Growth Factor Res. 3, 159 - 175.
Bonewald, L. F. and Dallas, S. L. (1994) Role of active and latent transforming growth factor beta in bone formation. J. Cell. Biochem. 55, 350 - 357.
Centrella, M., Horowitz, M. C., Wozney, J. M., and McCarthy, T. L. (1994) Transforming growth factor-beta gene family members and bone. Endocrine Rev. 15, 27 - 39.
Centrella, M., McCarthy, T. L., and Canalis, E. (1989) Effects of transforming growth factors on bone cells. Connect. Tissue Res. 20, 267 - 275.
Keller, J. R., Mcniece, I. K., Sill, K. T., Ellingsworth, L. R., Quesenberry, P. J., Sing, G. K., and Ruscetti, F. W. (1990) Transforming growth factor beta directly regulates primitive murine hematopoietic cell proliferation. Blood 75, 596 - 602.
Keller, J. R., Mantel, C., Sing, G. K., Ellingsworth, L. R., Ruscetti, S. K., and Ruscetti, F. W. (1988) Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines. J. Exp. Med. 168, 737 - 750.
RayChaudhury, A. and D’ Amore, P. A. (1991) Endothelial cell regulation by transforming growth factor-beta. J. Cell. Biochem. 47, 224 - 229.
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., et al. (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Nat. Acad. Sci. USA 83, 4167 - 4171.
Sporn, M. B. and Roberts, A. B. (1986) Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest. 78, 329 - 332.
Roberts, A. B., Flanders, K. C., Heine, U. I., Jakowlew, S., Kondaiah, P., Kim, S. J., and Sporn, M. B. (1990) Transforming growth factor-beta: multi-functional regulator of differentiation and development. Philos. Trans. R. Soc. London—Series B: Biol. Sci. 327, 145 - 154.
Roberts, A. B., Heine, U. I., Flanders, K. C., and Sporn, M. B. (1990) Transforming growth factor-beta. Major role in regulation of extracellular matrix. Ann. N. P. Acad. Sci. 580, 225 - 232.
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N., and Doetschman, T. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693 - 699.
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P., Ding, J., Ferguson, M. W. J., and Doetschman, T. (1995) Transforming growth factor-133 is required for secondary palate fusion. Nature Genetics 11, 409 - 414.
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., and Karlsson, S. (1993) Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Nat. Acad. Sci. USA 90, 770 - 774.
Kaartinen, V., Voncken, J. W., Shuler, C., Warburton, D., Heisterkamp, N., and Groffen, J. (1995) Abnormal lung development and cleft palate: Defects of epithelial-mesenchymal interaction in mice lacking TGF-03. Nature Genetics 11, 415 - 421.
Hines, K. L., Kulkarni, A. B., McCarthy, J. B., Tian, H., Ward, J. M., Christ, M., McCartney-Francis, N. L., Furcht, L. T., Karlsson, S., and Wahl, S. M. (1994) Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. Proc. Nat. Acad. Sci. USA 91, 5187 - 5191.
Diebold, R. J., Eis, M. J., Yin, M., Ormsby, I., Boivin, G. P., Darrow, B. J., Saffitz, J. E., and Doetschman, T. C. (1995) Early onset multifocal inflammation in the TGFB1-null mouse is lymphocyte mediated. Proc. Nat. Acad. Sci. USA 92, 12215 - 12219.
Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B., and Sporn, M. B. (1993) Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc. Nat. Acad. Sci. USA 90, 9944 —9948.
Dang, H., Geiser, A. G., Letterio, J. L., Nakabayashi, T., Kong, L., Fernandes, G., and Talal, N. (1995) SLE-like autoantibodies and Sjogren’s syndrome-like lymphoproliferation in TGF-ß knock out mice. J. Immunol. 155, 3205 - 3212.
Christ, M., McCartney-Francis, N. L., Kulkarni, A. B., Ward, J. M., Mizel, D. E., Mackall, C. L., Gress, R. E., Hines, K. L., Tian, H., Karlsson, S., et al. (1994) Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153, 1936 - 1946.
Boivin, G. P., O’Toole, B. A., Orsmby, I. E., Diebold, R. J., Eis, M. J., Doetschman, T., and Kier, A. B. (1995) Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am. J. Pathol. 146, 276 - 288.
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., and Akhurst, R. J. (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845 - 1854.
Shull, M. M., Diebold, R., Eis, M., Boivin, G., Grupp, I. L., and Doetschman, T. (1995) Homologous recombination and growth factors, in Molecular Genetics and Gene Therapy of Cardiovascular Diseases. (Mockrin. S. C. ed.) Dekker, New York, pp. 371 - 401.
Shull, M. M., Kier, A. B., Diebold, R. J., Yin, M., and Doetschman, T. (1994) The importance of transforming growth factor 131 in immunological homeostasis as revealed by gene ablation in mice, in Overexpression and Knockout of Cytokines in Transgenic Mice. ( Jacon, C. ed.), Academic, Chicago, pp. 135 - 159.
Brown, R. L., Ormsby, I. O., Doetschman, T. C., and Greenhalgh, D. G. (1995) Wound healing in the transforming growth factor-131—deficient mouse. Wound Repair Regeneration 3, 25 - 36.
Guenard, V., Rosenbaum, T., Gwynn, L. A., Doetschman, T., Ratner, N., and Wood, P. M. (1995) Effect of transforming growth factor-beta 1 and -beta 2 on Schwann cell proliferation on neurites. GLIA 13, 309 - 318.
Wahl, S. M. (1994) Transforming growth factor beta: the good, the bad, and the ugly. J. Exp. Med. 180, 1587 - 1590.
Sasaki, H., Pollard, R. B., Schmitt, D., and Suzuki, F. (1992) Transforming growth factor-beta in the regulation of the immune response. Clin. Immunol. Immunopath. 65, 1 - 9.
Kehrl, J. H., Taylor, A., Kim, S. J., and Fauci, A. S. (1991) Transforming growth factor-beta is a potent negative regulator of human lymphocytes. Ann. N. Y. Acad. Sci. 628, 345 - 353.
Roberts, A. B. and Sporn, M. B. (1990) The transforming growth factor-betas, in: Peptide Growth Factor and Their Receptors. ( Sporn, M. B. and Roberts, A. B., eds.), Springer-Verlag, Berlin, pp. 419 - 472.
Reibman, J., Meixler, S., Lee, T. C., Gold, L. I., Cronstein, B. N., Haines,K. A., Kolasinski, S. L., and Weissmann, G. (1991) Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses clas- sic signal-transduction pathways. Proc. Nat. Acad. Sci. USA 88, 6805 - 6809.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl,L. M., Roberts, A. B., and Sporn, M. B. (1987) Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Nat. Acad. Sci. USA 84, 5788 - 5792.
Gruber, B. L., Marchese, M. J., and Kew, R. R. (1994) Transforming growth factor-beta 1 mediates mast cell chemotaxis. J. Immunol. 152, 5860 - 5867.
Adams, D. H., Hathaway, M., Shaw, J., Burnett, D., Elias, E., and Strain, A. J. (1991) Transforming growth factor-beta induces human T lymphocyte migration in vitro. J. Immunol. 147, 609-612.
Parekh, T., Saxena, B., Reibman, J., Cronstein, B. N., and Gold, L. I. (1994) Neutrophil chemotaxis in response to TGF-beta isoforms (TGF-beta 1, TGF-beta 2, TGF-beta 3) is mediated by fibronectin. J. Immunol. 152, 2456 - 2466.
Chantry, D., Turner, M., Abney, E., and Feldmann, M. (1989) Modulation of cytokine production by transforming growth factor-beta. J. Immunol. 142, 4295 - 4300.
Wiseman, D. M., Polverini, P. J., Kamp, D. W., and Leibovich, S. J. (1988) Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem. Biophys. Res. Commun. 157, 793 - 800.
Turner, M., Chantry, D., and Feldmann, M. (1990) Transforming growth factor beta induces the production of interleukin 6 by human peripheral blood mononuclear cells. Cytokine 2, 211 - 216.
Welch, G. R., Wong, H. L., and Wahl, S. M. (1990) Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. J. Immunol. 144, 3444 - 3448.
Kehrl, J. H., Wakefield, L. M., Roberts, A. B., Jakowlew, S., Alvarez-Mon,M., Derynck, R., Sporn, M. B., and Fauci, A. S. (1986) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037 - 1050.
Wahl, S. M., Hunt, D. A., Wong, H. L., Dougherty, S., McCartney-Francis,N., Wahl, L. M., Ellingsworth, L., Schmidt, J. A., Hall, G., Roberts, A. B. and et al, (1988) Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140, 3026 - 3032.
Takahama, Y., Letterio, J. J., Suzuki, H., Farr, A. G. and Singer, A. (1994) Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta. J. Exp. Med. 179, 1495 - 1506.
Dubois, C. M., Ruscetti, F. W., Palaszynski, E. W., Falk, L. A., Oppenheim, J. J., and Keller, J. R. (1990) Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J. Exp. Med. 172, 737 - 744.
Turner, M., Chantry, D., Katsikis, P., Berger, A., Brennan, F. M., and Feldmann, M. (1991) Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta. Eur. J. Immunol. 21, 1635 - 1639.
Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., and Fauci, A. S. (1986) Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855 - 3860.
Kulkarni, A. B., Ward, J. M., Yaswen, L., Mackall, C. L., Bauer, S. R., Huh, C. G., Gress, R. E., and Karlsson, S. (1995) Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. Am. J. Pathol. 146, 264 - 275.
Akhurst, R. J., Fitzpatrick, D. R., Gatherer, D., Lehnert, S. A., and Millan, F. A. (1990) Transforming growth factor betas in mammalian embryogenesis. Prog. Growth Factor Res. 2, 153 - 168.
Paria, B. C., Jones, K. L., Flanders, K. C., and Dey, S. K. (1992) Localization and binding of transforming growth factor-beta isoforms in mouse preimplantation embryos and in delayed and activated blastocysts. Dev. Biol. 151, 91 - 104.
Slager, H. G., Lawson, K. A., van den Eijnden-Van Raaij, A. J., de Laat, S. W., and Mummery, C. L. (1991) Differential localization of TGF-beta 2 in mouse preimplantation and early postimplantation development. Dev. Biol. 145, 205 - 218.
Rappolee, D. A., Brenner, C. A., Schultz, R., Mark, D., and Werb, Z. (1988) Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos. Science 241, 1823-1825.
Akhurst, R. J., Lehnert, S. A., Gatherer, D., and Duffie, E. (1990) The role of TGF beta in mouse development. Ann. N. Y. Acad. Sci. 593, 259 - 271.
Heine, U., Munoz, E. F., Flanders, K. C., Ellingsworth, L. R., Lam, H. Y., Thompson, N. L., Roberts, A. B., and Sporn, M. B. (1987) Role of transforming growth factor-beta in the development of the mouse embryo. J. Cell Biol. 105 (2), 2861 - 2876.
Millan, F. A., Denhez, F., Kondaiah, P., and Akhurst, R. J. (1991) Embryonic gene expression patterns of TGF’ beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 111, 131 - 143.
Flanders, K. C., Ludecke, G., Engels, S., Cissel, D. S., Roberts, A. B., Kondaiah, P., Lafyatis, R., Sporn, M. B., and Unsicker, K. (1991) Localization and actions of transforming growth factor-betas in the embryonic nervous system. Development 113, 183 - 191.
Lehnert, S. A. and Akhurst, R. J. (1988) Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. Development 104, 263 - 273.
Fitzpatrick, D. R., Denhez, F., Kondaiah, P., and Akhurst, R. J. (1990) Differential expression of TGF beta isoforms in murine palatogenesis. Development 109, 585 - 595.
Gehris, A. L., D’ Angelo, M., and Greene, R. M. (1991) Immunodetection of the transforming growth factors beta 1 and beta 2 in the developing murine palate. Int. J. Dev. Biol. 35, 17 - 24.
Williams, J. M., Robinson, R. A., and Solursh, M. (1991) Immunohistochemical localization of TGF-B1 during morphogenetic movements of the developing mouse palate. J. Craniofacial Genetics Dev. Biol. 11, 138-145.
Pelton, R. W., Hogan, B. L., Miller, D. A., and Moses, H. L. (1990) Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev. Biol. 141, 456-460.
Potts, J. D., Dagle, J. M., Walder, J. A., Weeks, D. L., and Runyan, R. B. (1991) Epithelial—mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. Proc. Nat. Acad. Sci. USA 88, 1516 - 1520.
Potts, J. D. and Runyan, R. B. (1989) Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. Dev. Biol. 134, 392 - 401.
Timme, T. L., Truong, L. D., Merz, V. W., Krebs, T., Kadmon, D., Flanders, K. C., Park, S. H., and Thompson, T. C. (1994) Mesenchymal—epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology 134, 1039 - 1045.
Pelton, R. W., Saxena, B., Jones, M., Moses, H. L., and Gold, L. I. (1991) Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J. Cell Biol. 115, 1091 - 1105.
Akhurst, R. J., Lehnert, S. A., Faissner, A., and Duffie, E. (1990) TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108, 645 - 656.
Heimark, R. L., Twardzik, D. R., and Schwartz, S. M. (1986) Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233, 1078 - 1080.
Muller, G., Behrens, J., Nussbaumer, U., Bohlen, P., and Birchmeier, W. (1987) Inhibitory action of transforming growth factor beta on endothelial cells. Proc. Nat. Acad. Sci. USA 84, 5600 - 5604.
Ohta, M., Greenberger, J. S, Anklesaria, P., Bassols, A., and Massague, J. (1987) Two forms of transforming growth factor-beta distinguished by multipotential haematopoietic progenitor cells. Nature 329, 539 - 541.
Ottmann, O. G. and Pelus, L. M. (1988) Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. J. Immunol. 140, 2661 - 2665.
Sing, G. K., Keller, J. R., Ellingsworth, L. R., and Ruscetti, F. W. (1988) Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72, 1504 - 1511.
Carlino, J. A., Higley, H. R., Avis, P. D., Chu, S. S., Ogawa, Y., and Ellingsworth, L. R. (1990) Hematologic and hematopoietic changes induced by systemic administration of TGF(31, in Transforming Growth Factor-/3s: Chemistry, Biology, and Therapeutics ( Piez, K. A. and Sporn, M. B., eds.), New York Academy of Sciences, New York, pp. 330 - 333.
Jansen, R., Damia, G., Usui, N., Keller, J., Futami, H., Goey, H., Back, T. T., Longo, D. L., Ruscetti, F. W., and Wiltrout, R. H. (1991) Effects of recombinant transforming growth factor-beta 1 on hematologic recovery after treatment of mice with 5-fluorouracil. J. Immunol. 147, 3342 - 3347.
Carlino, J. A., Higley, H. R., Creson, J. R., Avis, P. D., Ogawa, Y., and Ellingsworth, L. R. (1992) Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. Exp. Hematol. 20, 943 - 950.
Miller, K. L., Carlino, J. A., Ogawa, Y., Avis, P. D., and Carroll, K. G. (1992) Alterations in erythropoiesis in TGF-beta 1-treated mice. Exp. Hematol. 20, 951 - 956.
Letterio, J. J., Geiser, A. G., Kulkarni, A. B., Roche, N. S., Sporn, M. B., and Roberts, A. B. (1994) Maternal rescue of transforming growth factor-beta 1 null mice. Science 264, 1936 - 1938.
Jennings, E. R. and Clauss, B. (1978) Maternal-fetal hemorrhage: its incidence and sensitizing effects. Am. J. Obstet. Gynecol. 131, 725 - 727.
Benahmed, M., Morera, A. M., Ghiglieri, C., Tabone, E., Menezo, Y., Hendrick, J. C., and Franchimont, P. (1993) Transforming growth factorbeta(s) in the ovary. Ann. N. Y. Acad. Sci. 687, 13 - 19.
Chegini, N. and Flanders, K. C. (1992) Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology 130, 1707 - 1715.
Roy, S. K., Ogren, C., Roy, C., and Lu, B. (1992) Cell-type-specific localization of transforming growth factor-beta 2 and transforming growth factor-beta 1 in the hamster ovary: differential regulation by follicle-stimulating hormone and luteinizing hormone. Biol. Reprod. 46, 595 - 606.
Teerds, K. J. and Dorrington, J. H. (1992) Immunohistochemical localization of transforming growth factor-beta 1 and -beta 2 during follicular development in the adult rat ovary. Mol. and Cell. Endocrinology 84, R7 — R13.
Dorrington, J., Chuma, A. V., and Bendell, J. J. (1988) Transforming growth factor beta and follicle-stimulating hormone promote rat granulosa cell proliferation. Endocrinology 123, 353 - 359.
May, J. V., Frost, J. P., and Schomberg, D. W. (1988) Differential effects of epidermal growth factor, somatomedin-C/insulin-like growth factor I, and transforming growth factor-beta on porcine granulosa cell deoxyribonucleic acid synthesis and cell proliferation. Endocrinology 123, 168 - 179.
Skinner, M. K., Keski-Oja, J., Osteen, K. G., and Moses, H. L. (1987) Ovarian thecal cells produce transforming growth factor-beta which can regulate granulosa cell growth. Endocrinology 121, 786 - 792.
Ying, S. Y., Becker, A., Ling, N., Ueno, N., and Guillemin, R. (1986) Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochem. Biophys. Res. Commun. 136, 969 - 975.
Dodson, W. C. and Schomberg, D. W. (1987) The effect of transforming growth factor-beta on follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 120, 512 - 516.
Hutchinson, L. A., Findlay, J. K., de Vos, F. L., and Robertson, D. M. (1987) Effects of bovine inhibin, transforming growth factor-beta and bovine Activin-A on granulosa cell differentiation. Biochem. Biophys. Res. Commun. 146, 1405 - 1412.
Knecht, M., Feng, P., and Catt, K. (1987) Bifunctional role of transforming growth factor-beta during granulosa cell development. Endocrinology 120, 1243 - 1249.
Adashi, E. Y., Resnick, C. E., Hernandez, E. R., May, J. V., Purchio, A. F., and Twardzik, D. R. (1989) Ovarian transforming growth factor-beta (TGF beta): cellular site(s), and mechanism(s) of action. Mol. Cell. Endocrinology 61, 247 - 256.
Magoffin, D. A., Gancedo, B., and Erickson, G. F. (1989) Transforming growth factor-beta promotes differentiation of ovarian thecal-interstitial cells but inhibits androgen production. Endocrinology 125, 1951 - 1958.
Hernandez, E. R., Hurwitz, A., Payne, D. W., Dharmarajan, A. M., Purchio, A. F., and Adashi, E. Y. (1990) Transforming growth factor-beta 1 inhibits ovarian androgen production: gene expression, cellular localization, mechanisms(s), and site(s) of action. Endocrinology 127, 2804 - 2811.
Caubo, B., DeVinna, R. S., and Tonetta, S. A. (1989) Regulation of steroidogenesis in cultured porcine theca cells by growth factors. Endocrinology 125, 321 - 326.
Feng, P., Catt, K. J., and Knecht, M. (1986) Transforming growth factor beta regulates the inhibitory actions of epidermal growth factor during granulosa cell differentiation. J. Biol. Chem. 261, 14,167-14, 170.
Knecht, M., Feng, P., and Catt, K. J. (1986) Transforming growth factor-beta regulates the expression of luteinizing hormone receptors in ovarian granulosa cells. Biochem. Biophys. Res. Commun. 139, 800 - 807.
Mondschein, J. S., Canning, S. F., and Hammond, J. M. (1988) Effects of transforming growth factor-beta on the production of immunoreactive insulin-like growth factor I and progesterone and on [3H]thymidine incorporation in porcine granulosa cell cultures. Endocrinology 123, 1970 - 1976.
Matsuyama, S., Shiota, K., and Takahashi, M. (1990) Possible role of transforming growth factor-beta as a mediator of luteotropic action of prolactin in rat luteal cell cultures. Endocrinology 127, 1561 - 1567.
Tsafriri, A., Vale, W., and Hsueh, A. J. (1989) Effects of transforming growth factors and inhibin-related proteins on rat preovulatory graafian follicles in vitro. Endocrinology 125, 1857 - 1862.
Feng, P., Catt, K. J., and Knecht, M. (1988) Transforming growth factor-beta stimulates meiotic maturation of the rat oocyte. Endocrinology 122, 181 - 186.
Howe, P. H., Draetta, G., and Leof, E. B. (1991) Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with Gl/S-phase growth arrest. Mol. Cell. Biol. 11, 1185 - 1194.
Gabrielli, B. G., Roy, L. M., and Mailer, J. L. (1993) Requirement for Cdk2 in cytostatic factor-mediated metaphase II arrest. Science 259, 1766 - 1769.
Hampl, A. and Eppig, J. J. (1995) Analysis of the mechanism(s) of metaphase I arrest in maturing mouse oocytes. Development 121, 925— 933.
Altman, D. J., Schneider, S. L., Thompson, D. A., Cheng, H. L., and Tomasi, T. B. (1990) A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus. J. Exp. Med. 172, 1391 - 1401.
Tamada, H., McMaster, M. T., Flanders, K. C., Andrews, G. K., and Dey, S. K. (1990) Cell type-specific expression of transforming growth factor-beta 1 in the mouse uterus during the periimplantation period. Mol. Endocrinology 4, 965 - 972.
Dungy, L. J., Siddiqi, T. A., and Khan, S. (1991) Transforming growth factor-beta 1 expression during placental development. Am. J. Obstet. Gynecol. 165 (1), 853 - 857.
Das, S. K., Flanders, K. C., Andrews, G. K., and Dey, S. K. (1992) Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. Endocrinology 130, 3459 - 3466.
Lea, R. G., Flanders, K. C., Harley, C. B., Manuel, J., Banwatt, D., and Clark, D. A. (1992) Release of a transforming growth factor (TGF)-beta 2-related suppressor factor from postimplantation murine decidual tissue can be correlated with the detection of a subpopulation of cells containing RNA for TGF-beta 2. J. Immunol. 148, 778 - 787.
Manova, K., Paynton, B. V., and Bachvarova, R. F. (1992) Expression of activins and TGF beta 1 and beta 2 RNAs in early postimplantation mouse embryos and uterine decidua. Mech. Dey. 36, 141 - 152.
Graham, C. H. and Lala, P. K. (1991) Mechanism of control of trophoblast invasion in situ. J. Cell. Physiol. 148, 228 - 234.
Clark, D. A., Falbo, M., Rowley, R. B., Banwatt, D., and Stedronska-Clark, J. (1988) Active suppression of host-vs graft reaction in pregnant mice. IX. Soluble suppressor activity obtained from allopregnant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor-beta. J. Immunol. 141, 3833 - 3840.
Clark, D. A., Flanders, K. C., Banwatt, D., Millar-Book, W., Manuel, J., Stedronska-Clark, J., and Rowley, B. (1990) Murine pregnancy decidua produces a unique immunosuppressive molecule related to transforming growth factor beta-2. J. Immunol. 144, 3008.-3014.
Skinner, M. K. (1991) Cell-cell interactions in the testis. Endocrine Rev. 12, 45 - 77.
Skinner, M. K., Norton, J. N., Mullaney, B. P., Rosselli, M., Whaley, P. D., and Anthony, C. T. (1991) Cell-cell interactions and the regulation of testis function. Ann. N. Y. Acad. Sci. 637, 354 - 363.
Gautier, C., Levacher, C., Avallet, O., Vigier, M., Rouiller-Fabre, V., Lecerf, L., Saez, J., and Habert, R. (1994) Immunohistochemical localization of transforming growth factor-beta 1 in the fetal and neonatal rat testis. Mol. Cell. Endocrinology 99, 55 - 61.
Mullaney, B. P. and Skinner, M. K. (1993) Transforming growth factor-beta (beta 1, beta 2, and beta 3) gene expression and action during pubertal development of the seminiferous tubule: potential role at the onset of spermatogenesis. Mol. Endocrinol. 7, 67 - 76.
Watrin, F., Scotto, L., Assoian, R. K., and Wolgemuth, D. J. (1991) Cell lineage specificity of expression of the murine transforming growth factor beta 3 and transforming growth factor beta 1 genes. Cell Growth Differ. 2, 77 - 83.
Avallet, O., Vigier, M., Perrard-Sapori, M. H., and Saez, J. M. (1987) Transforming growth factor beta inhibits Leydig cell functions. Biochem. Biophys. Res. Commun. 146, 575 - 581.
Fauser, B. C. and Hsueh, A. J. (1988) Effect of transforming growth factor-beta on human chorionic gonadotropin induced testosterone production by cultured rat testicular cells. Life Sci. 43, 1363 - 1370.
Lin, T., Blaisdell, J., and Haskell, J. F. (1987) Transforming growth factor-beta inhibits Leydig cell steroidogenesis in primary culture. Biochem. Biophys. Res. Commun. 146, 387 - 394.
Morera, A. M., Cochet, C., Keramidas, M., Chauvin, M. A., de Peretti, E., and Benahmed, M. (1988) Direct regulating effects of transforming growth factor beta on the Leydig cell steroidogenesis in primary culture. J. Steroid Biochem. 30, 443 - 447.
Skinner, M. K. and Moses, H. L. (1989) Transforming growth factor beta gene expression and action in the seminiferous tubule: peritubular cellSertoli cell interactions. Mol. Endocrinol. 3, 625 - 634.
Teerds, K. J. and Dorrington, J. H. (1993) Localization of transforming growth factor beta 1 and beta 2 during testicular development in the rat. Biol. Reprod. 48, 40 - 45.
Matzuk, M. M., Finegold, M. J., Mather, J. P., Krummen, L., Lu, H., and Bradley, A. (1994) Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Nat. Acad. Sci. USA 91, 8817 - 8821.
Plata-Salaman, C. R., Oomura, Y., and Kai, Y. (1988) Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system. Brain Res. 448, 106 - 114.
Tracey, K. J., Morgello, S., Koplin, B., Fahey, T. J., 3d, Fox, J., Aledo, A., Manogue, K. R., and Cerami, A. (1990) Metabolic effects of cachectin/ tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J. Clin. Invest. 86, 2014 - 2024.
Nicholson, A. C. and Hajjar, D. P. (1992) Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells. J. Biol. Chem. 267, 25982 - 25987.
Dajani, A. S., Taubert, K. A., Gerber, M. A., Shulman, S. T., Ferrien, P., Freed, M., Takahashi, M., Bierman, F. Z., Karchmer, A. W., Wilson, W., et al. (1993) Diagnosis and therapy of Kawasaki disease in children. Circulation 87, 1776 - 1780.
Furukawa, S., Imai, K., Matsubara, T., Yone, K., Yachi, A., Okumura, K., and Yabuta, K. (1992) Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum. 35, 672 - 677.
Furukawa, S., Matsubara, T., Yone, K., Hirano, Y., Okumura, K., and Yabuta, K. (1992) Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur. J. Pediatr. 151, 44 - 47.
Gulick, T., Chung, M. K., Pieper, S. J., Lange, L. G., and Schreiner, G. F. (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc. Nat. Acad. Sci. USA 86, 6753 - 6757.
Lefer, A. M., Tsao, P., Aoki, N., and Palladino, M. A., Jr. (1990) Mediation of cardioprotection by transforming growth factor-beta. Science 249, 61 - 64.
Roberts, A. B., Roche, N. S., Winokur, T. S., Burmester, J. K., and Sporn, M. B. (1992) Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1. J. Clin. Invest. 90, 2056 - 2062.
Lefer, A. M., Ma, X. L., Weyrich, A. S., and Scalia, R. (1993) Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proc. Nat. Acad. Sci. USA 90, 1018 - 1022.
Ridley, A. J., Davis, J. B., Stroobant, P., and Land, H. (1989) Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells. J. Cell Biol. 109 (2), 3419 - 24.
Eccleston, P. A., Jessen, K. R., and Mirsky, R. (1989) Transforming growth factor-beta and gamma-interferon have dual effects on growth of peripheral glia. J. Neurosci. Res. 24, 524 - 530.
Rogister, B., Delree, P., Leprince, P., Martin, D., Sadzot, C., Malgrange, B., Munaut, C., Rigo, J. M., Lefebvre, P. P., Octave, J. N. and et al, (1993) Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J. Neurosci. Res. 34, 32 - 43.
Schubert, D. (1992) Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis. J. Neurobiol. 23, 143 - 148.
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., Barnard, J. A., Yuspa, S., Coffey, R. J., and Magnuson, T. (1995) Targeted disruption of mouse EGF Receptor: Effect of genetic background on mutant phenotype. Science 269, 230 - 234.
Sibilia, M. and Wagner, E. F. (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234 - 238.
Winnier, G., Blessing, M., Labosky, P. A., and Hogan, B. L. M. (1995) Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Devel. 9, 2105 - 2116.
Derynck, R., Lindquist, P. B., Lee, A., Wen, D., Tamm, J., Graycar, J. L., Rhee, L., Mason, A. J., Miller, D. A., Coffey, R. J., et al, (1988) A new type of transforming growth factor-beta, TGF-beta 3. EMBO J. 7, 3737 - 3743.
ten Dijke, P., Hansen, P., Iwata, K. K., Pieler, C., and Foulkes, J. G. (1988) Identification of another member of the transforming growth factor type beta gene family. Proc. Nat. Acad. Sci. USA 85, 4715 - 4719.
Pelton, R. W., Dickinson, M. E., Moses, H. L., and Hogan, B. L. (1990) In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development 110, 609 - 620.
Flanders, K. C., Ludecke, G., Engels, S., Cissel, D. S., Roberts, A. B., Kondaiah, P., Lafyatis, R., Sporn, M. B., and Unsicker, K. (1991) Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development 113, 183 - 191.
Vassalli, A., Matzuk, M. M., Gardner, H. A., Lee, K. F., and Jaenisch, R. (1994) Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Devel. 8, 414 - 427.
Matzuk, M. M., Kumar, T. R., Vassalli, A., Bickenbach, J. R., Roop, D. R., Jaenisch, R., and Bradley, A. (1995) Functional analysis of activins during mammalian development. Nature 374, 354 - 356.
Matzuk, M. M., Finegold, M. J., Su, J. G., Hsueh, A. J., and Bradley, A. (1992) Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360, 313 - 319.
Kingsley, D. M., Bland, A. E., Grubber, J. M., Marker, P. C., Russell, L. B., Copeland, N. G., and Jenkins, N. A. (1992) The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71, 399 - 410.
Dudley, A. T., Lyons, K. M., and Robertson, E. J. (1995) A requirement for bone morphogenetic protein-7 during development of mammalian kidney and eye. Genes Devel. 9, 2795 - 2807.
Luo, G., Hofmann, C., Bronckers, A. L. J. J., Sohocki, M., Bradley, A., and Karsenty, G. (1995) BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Devel. 9, 2808 - 2820.
Ames, B. N., Gold, L. S., and Willett, W. C. (1995) The causes and prevention of cancer. Proc. Nat. Acad. Sci. USA 92, 5258 - 5265.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kallapur, S., Shull, M., Doetschman, T. (1998). Phenotypes of TGFß Knockout Mice. In: Durum, S.K., Muegge, K. (eds) Cytokine Knockouts. Contemporary Immunology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-2753-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2753-1_19
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-2755-5
Online ISBN: 978-1-4757-2753-1
eBook Packages: Springer Book Archive